Deciphering a Novel and Unique Brown Adipose Tissue Depot in Women

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-22
SponsorUniversidad de Almeria

About this trial

Type of Study: Clinical Trial

Goal: The goal of this clinical trial is to investigate specific brown and beige fat cells in the dorsocervical area of young, lean adult women.

Participant Population/Health Conditions: The study will involve 40 young, lean adult women.

Main Questions: The main questions this study aims to answer are:

* Are there active brown or beige adipocytes in the subcutaneous fat of the dorsocervical area (i.e., iBAT)? * What is the secretory function of these adipocytes? * How do traditional interventions like cold exposure, as well as new approaches like Beta-2 agonist stimulation and exercise, affect the thermogenesis of these fat cells at the cellular and molecular levels?

Participants Will:

Be randomized into one of four groups: thermoneutral exposure, cold exposure, aerobic exercise, or Beta-2 agonist treatment.

Follow their assigned regimen for 4 weeks. Provide tissue samples from the dorsocervical area and abdomen before and after the 4-week intervention.

Undergo analysis of these samples using advanced techniques to understand the presence and activity of brown and beige fat cells.

Comparison Group: Researchers will compare the effects of different interventions (thermoneutral exposure, cold exposure, aerobic exercise, Beta-2 agonist treatment) on the presence and thermogenesis of brown and beige fat cells in the dorsocervical area.

Eligibility criteria

Qualifiers

18-22 years of age women.

BMI between ≥18 and <25 kg/m2

Are willing to be randomized to either of these 4 groups.

Must be sedentary (i.e., do not perform exercise or go to the gym).

Disqualifiers

Diabetes mellitus (determined based on fasting glucose levels defined by ADA criteria).

Any other active endocrine disease (thyroid disease, any signs of Cushing's syndrome, adrenal disease and lipid-associated disorders such as familial hypercholesterolemia).

Any cardiac disease (i.e., ischemic cardiac disease, arrhythmias, severe heart failure).

Use of medication known to influence glucose and/or lipid metabolism or brown fat activity (e.g., beta-blockers, antidepressants, corticosteroids).

Trial design

Treatments tested in this trial

  • Thermoneutral condition
  • Cold condition
  • Aerobic exercise condition
  • Salbutamol

Treatment groups

40 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Universidad de Almeria

Lead sponsor

Leiden University Medical Center

Collaborator

ETH Zurich (Switzerland)

Collaborator